Some tasks produce a performance advantage for conditions that require the processing of stimuli in two visual fields compared to conditions where single hemifield processing is sufficient. This advantage, however, disappears with practice. Although no definitive evidence yet exists, there are several possible mechanisms that might lead to improved performance of within- compared to across-hemisphere processing with practice. These include a shift from a more demanding, algorithmic strategy to a less demanding memory-retrieval strategy (e.g., [G. Logan, Toward an instance theory of automatisation. Psych. Rev. 95 (1988) 492-527]), as discussed by Weissman and Compton [D.H. Weissman, R.J. Compton, Practice makes a hemisphere perfect: the advantage of interhemispheric recruitment is eliminated with practice. Laterality, 8 (4) (2003) 361-375], and/or a more generalised practice effect [K. Kirsner, C. Speelman, Skill acquisition and repetition priming: one principle, many processes? J. Exp. Psychol., Learn. Mem. Cogn., 22 (1996) 563-575]. Contrary to Weissman and Compton findings, our results suggest that although single-hemisphere performance improves with practice, bi-hemispheric performance also improves substantially. Furthermore, these effects do not appear to be due to a shift in strategy but rather due to a general practice effect.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.cogbrainres.2005.02.010 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers.
BJU Int
September 2024
Netherlands Cancer Institute, Amsterdam, Netherlands.
Objectives: To report the long-term outcomes from a longitudinal psychosocial study that forms part of the 'Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted Screening in men at higher genetic risk and controls' (IMPACT) study. The IMPACT study is a multi-national study of targeted prostate cancer (PrCa) screening in individuals with a known germline pathogenic variant (GPV) in either the BReast CAncer gene 1 (BRCA1) or the BReast CAncer gene 2 (BRCA2).
Subjects And Methods: Participants enrolled in the IMPACT study were invited to complete a psychosocial questionnaire prior to each annual screening visit for a minimum of 5 years.
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.
Lancet Oncol
November 2021
Oncogenetics Team, Institute of Cancer Research, London, UK; Cancer Genetics Unit & Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK. Electronic address:
Article Synopsis
- Lynch syndrome is a hereditary cancer syndrome linked to mutations in mismatch repair genes, increasing the risk for various cancers, especially colorectal and endometrial cancer, and recently identified as a risk factor for early-onset aggressive prostate cancer.
- The IMPACT study, an international research project, is evaluating the effectiveness of prostate-specific antigen (PSA) screening among men aged 40-69 with and without these genetic variants to determine the incidence and characteristics of prostate cancer.
- Initial findings from the first round of PSA screenings indicate differences in prostate cancer detection and characteristics between men with pathogenic variants compared to age-matched controls who do not carry these variants.
Measuring the predictability of life outcomes with a scientific mass collaboration.
Proc Natl Acad Sci U S A
April 2020
Department of Sociology, Princeton University, Princeton, NJ 08544;
How predictable are life trajectories? We investigated this question with a scientific mass collaboration using the common task method; 160 teams built predictive models for six life outcomes using data from the Fragile Families and Child Wellbeing Study, a high-quality birth cohort study. Despite using a rich dataset and applying machine-learning methods optimized for prediction, the best predictions were not very accurate and were only slightly better than those from a simple benchmark model. Within each outcome, prediction error was strongly associated with the family being predicted and weakly associated with the technique used to generate the prediction.
View Article and Find Full Text PDFThe development and utility of a novel scale that quantifies the glycemic progression toward type 1 diabetes over 6 months.
Diabetes Care
May 2015
VA Puget Sound Health Care System; Division of Endocrinology, Metabolism, and Nutrition, University of Washington, Seattle, WA.
Objective: We developed a scale to serve as a potential end point for 6-month glycemic progression (PS6M) toward type 1 diabetes (T1D) in autoantibody-positive relatives of individuals with T1D.
Research Design And Methods: The PS6M was developed from Diabetes Prevention Trial-Type 1 (DPT-1) data and tested in the TrialNet Pathway to Prevention Study (PTP). It is the difference between 6-month glucose sum values (30-120 min oral glucose tolerance test values) and values predicted for nonprogressors.
Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.
Eur Urol
September 2014
Oncogenetics Team, Institute of Cancer Research, London, UK; Cancer Genetics Unit and Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK. Electronic address:
Background: Men with germline breast cancer 1, early onset (BRCA1) or breast cancer 2, early onset (BRCA2) gene mutations have a higher risk of developing prostate cancer (PCa) than noncarriers. IMPACT (Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted screening in BRCA1/2 mutation carriers and controls) is an international consortium of 62 centres in 20 countries evaluating the use of targeted PCa screening in men with BRCA1/2 mutations.
Objective: To report the first year's screening results for all men at enrollment in the study.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!